Literature DB >> 20333348

[Stroke in cancer patients. A paraneoplastic neurological syndrome?].

W Grisold1, M Födinger, S Oberndorfer.   

Abstract

The coincidence of stroke and cancer is frequently encountered. From recent epidemiological data, the stroke risk in cancer patients seems to be equally distributed as compared to the non-cancer population. However, there are several clinical conditions in cancer patients which increase the risk for stroke: Trousseau's syndrome, non-bacterial thrombotic endocarditis and disseminated intravascular coagulation. Also some tumour-specific conditions such as coagulopathies, changes of viscosity and cellular mechanisms such as leukocytosis or thrombocytopathies must be considered. In several types of tumour treatment, such as various anticancer drugs, an increased occurrence of stroke has been reported. Presently there is no indication that stroke and cancer are related to the immune-mediated "classic" paraneoplastic syndromes. However, there are several cancer-specific types and causes of stroke which need to be considered in each patient, as they can be of significance in the treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20333348     DOI: 10.1007/s00115-010-2952-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  38 in total

1.  Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.

Authors:  L Campiotti; A M Grandi; M G Biotti; C Ultori; F Solbiati; R Codari; A Venco
Journal:  Am J Hematol       Date:  2007-03       Impact factor: 10.047

Review 2.  Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.

Authors:  Ronald A Asherson
Journal:  Immunobiology       Date:  2005-10-20       Impact factor: 3.144

3.  High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer.

Authors:  T G Jovin; V Boosupalli; S A Zivkovic; L R Wechsler; J M Gebel
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

4.  Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Authors:  Gianmauro Numico; Ornella Garrone; Vincenzo Dongiovanni; Nicola Silvestris; Ida Colantonio; Gianna Di Costanzo; Cristina Granetto; Marcella Occelli; Elena Fea; Abdelamid Heouaine; Milena Gasco; Marco Merlano
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Elevated plasma levels of the factor Xa-TFPI complex in cancer patients.

Authors:  Nina Iversen; Anne Karin Lindahl; Ulrich Abildgaard
Journal:  Thromb Res       Date:  2002-01-01       Impact factor: 3.944

Review 6.  Cerebrovascular complications in cancer patients.

Authors:  Lisa R Rogers
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

7.  Prothrombotic States that Predispose to Stroke.

Authors:  Bradley K. Hiatt; Steven R. Lentz
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

8.  Recurrent cerebral venous thrombosis revealing paraneoplastic angiitis in Hodgkin's lymphoma.

Authors:  Stephanie Roggerone; Alexandra Traverse-Glehen; Laurent Derex; Jerome Honnorat; Francoise Berger; Gilles Salles; Hugues Rousset; Paul Trouillas; Norbert Nighoghossian
Journal:  J Neurooncol       Date:  2008-05-07       Impact factor: 4.130

9.  Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.

Authors:  J M Baehring; R K Fulbright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

10.  FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.

Authors:  Martin H Cohen; Joe Gootenberg; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2007-06
View more
  1 in total

1.  Ovarian Cancer Presenting as Cryptogenic Stroke from Patent Foramen Ovale.

Authors:  Bindu R Potugari; Priyanka Priyanka; Sarah D Komanapalli; Richard J Mercier
Journal:  Clin Med Res       Date:  2019-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.